Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine

Por Chiara Agrati, Concetta Castilletti, Delia Goletti, Alessandra Sacchi, Veronica Bordoni, Davide Mariotti, Stefania Notari, Giulia Matusali, Silvia Meschi, Linda Petrone, Alessandra Aiello, Saeid Najafi Fard, Chiara Farroni, Francesca Colavita, Daniele Lapa, Sara Leone, Alessandro Agresta, Maria Capobianchi, Giuseppe Ippolito, Francesco Vaia, Vincenzo Puro, INMI COVID-19 Vaccine Study Group
Publicado em 2022-04-01